Company / Shares Outstanding
NovoCure Ltd Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
108.5M
FY2025
5-year range
102.3M / 108.5M
FY2021-FY2025
Trend
+1.3%
vs FY2024
Sector context
#77 of 165
Health Care
What the data says
At 108516819.00, NovoCure Ltd's shares outstanding ranks #89 of 165 in the Health Care sector. Shares Outstanding has increased for 9 consecutive years, from 83778581.00 in FY2016 to 108516819.00 in FY2025.
Based on SEC 10-K filings.
108516819.00 in FY2025 with a 5-year CAGR of +1.7%.
Increased from 105049411.00 to 108516819.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +1.4%
- 5-Year CAGR
- +1.7%
- 10-Year CAGR
- -
Sector benchmark
#89 of 165 in Health CareTop 53% of 165This company 108.5M Sector average 170.3M
▼
-36.3% below sector average
Key checks
Key Insights
- NovoCure Ltd's shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 1.3% year-over-year.
- Ranks #77 out of 165 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 108.5M | +1.3% |
| FY2024 | 107.1M | +1.9% |
| FY2023 | 105.0M | +1.0% |
| FY2022 | 104.0M | +1.6% |
| FY2021 | 102.3M | +2.8% |
| FY2020 | 99.5M | +6.7% |
| FY2019 | 93.3M | +4.2% |
| FY2018 | 89.5M | +2.8% |
| FY2017 | 87.1M | +3.9% |
| FY2016 | 83.8M | +523.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026